XML 189 R8.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Millions
Total
Class A Common Stock
Common Stock
Class A Common Stock
Treasury Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Non-Controlling Interest
Beginning of period (in shares) at Mar. 31, 2022     164,372,545          
Beginning of period at Mar. 31, 2022 $ 1,048   $ 2 $ (1,635) $ 656 $ 2,015 $ 9 $ 1
Treasury stock (in shares) at Mar. 31, 2022       (31,788,197)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock (in shares)     1,170,726          
Issuance of common stock 25       25      
Stock options exercised (in shares)     329,061          
Stock options exercised 11       11      
Repurchase of common stock (in shares)   (2,100,000)   (2,446,547) [1]        
Repurchase of common stock (225) [1] $ (196)   $ (225) [1]        
Net income 271         272   (1)
Other comprehensive income, net of tax 21           21  
Dividends paid (236)         (236)    
Stock-based compensation expense 80       80      
Contribution to non-controlling interest 0       (3)     3
De-Consolidation of non-controlling interest (3)             (3)
End of period (in shares) at Mar. 31, 2023     165,872,332          
End of period at Mar. 31, 2023 992   $ 2 $ (1,860) 769 2,051 30 0
Treasury stock (in shares) at Mar. 31, 2023       (34,234,744)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock (in shares)     1,194,324          
Issuance of common stock 29       29      
Stock options exercised (in shares)     335,612          
Stock options exercised 16       16      
Repurchase of common stock (in shares)   (3,200,000)   (3,524,401) [1]        
Repurchase of common stock (418) [1] $ (373)   $ (418) [1]        
Net income 606         606   0
Other comprehensive income, net of tax (20)           (20)  
Dividends paid (253)         (253)    
Stock-based compensation expense $ 95       95      
End of period (in shares) at Mar. 31, 2024 129,643,123   167,402,268          
End of period at Mar. 31, 2024 $ 1,047   $ 2 $ (2,278) 909 2,404 10 0
Treasury stock (in shares) at Mar. 31, 2024 (37,759,145)     (37,759,145)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock (in shares)     1,022,351          
Issuance of common stock $ 34       34      
Stock options exercised (in shares)     97,925          
Stock options exercised 5       5      
Repurchase of common stock (in shares)   (5,600,000)   (5,884,395) [1]        
Repurchase of common stock (804) [1] $ (764)   $ (804) [1]        
Net income 935         935   0
Other comprehensive income, net of tax (39)           (39)  
Dividends paid (269)         (269)    
Stock-based compensation expense $ 94       94      
End of period (in shares) at Mar. 31, 2025 124,879,004   168,522,544          
End of period at Mar. 31, 2025 $ 1,003   $ 2 $ (3,082) $ 1,042 $ 3,070 $ (29) $ 0
Treasury stock (in shares) at Mar. 31, 2025 (43,643,540)     (43,643,540)        
[1] During fiscal 2025, 2024, and 2023, the Company purchased 5.6 million, 3.2 million and 2.1 million shares, respectively, of the Company’s Class A Common Stock for $764 million, $373 million, and $196 million, respectively. Additionally, during fiscal 2025, 2024, and 2023, the Company repurchased shares for $40 million, $45 million and $29 million, respectively, to cover the minimum statutory taxes on repurchases and restricted stock units that vested on various dates during those years.